[{"_1":2,"_3":-5,"_4":-5},"loaderData",{"_5":6,"_7":8},"actionData","errors","root",{"_96":97},"routes/item",{"_9":10},"item",{"_11":12,"_13":14,"_15":16,"_17":18,"_19":20,"_21":-5,"_22":23,"_24":25,"_26":27,"_28":29,"_30":29,"_31":32,"_33":34,"_35":36,"_37":38,"_39":40,"_41":42,"_43":44,"_45":-5,"_46":47,"_48":-5,"_49":-5,"_50":51,"_52":53,"_54":55,"_56":57,"_58":57,"_59":60,"_61":40,"_62":63},"id","aphe9aiw777ioayxiprsqdvor","revision",2,"title","CVS Health宣布拟分拆为两家独立上市公司","originalTitle","CVS HEALTH Corp (0000064803) (Filer)","summary","CVS Health于11月4日宣布，拟通过一项旨在符合美国联邦所得税免税处理的交易，分拆为两家独立上市公司。公司在8-K中将新闻稿作为附件提交；材料未说明分拆时间表或具体安排。","reason","source",{"_11":86,"_87":88,"_89":90,"_91":57,"_92":93,"_94":95},"links",{"_83":84,"_63":85},"publishedAt","2026-11-04T11:34:02.000Z","discoveredAt","2026-11-04T11:59:34.250Z","timelineAt","category","ai-products","tags",[82],"stockSymbols",[81],"score",53,"selected",false,"channel","news","story",{"_73":74,"_15":75},"x","readingMode","full","author","language","body",{"_77":-5,"_63":78,"_79":-5,"_80":40},"outline",[],"relatedStories",[76],"indexable",true,"markdownAvailable","group",{"_64":65,"_43":66,"_67":68,"_69":70,"_71":72},"hasTranslation","bodyLanguage","original","factId","fpsQz-uY9YXo",{"_73":74,"_15":75},"reportCount",8,"additionalSourceCount",5,"developmentCount",0,"publicId","c117569b-a631-4863-a237-98a0983a677d","CVS Health计划分拆零售药房与健康业务",{"_73":74,"_15":75},"zh","

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

Form 8-K

CURRENT REPORT

Pursuant to Section 13 or 15(d)

of the Securities Exchange Act of 1934

Date of report (Date of earliest event reported): November 4, 2026

\n $\"LOGO\"$

CVS HEALTH CORPORATION

(Exact name of registrant as specified in its charter)

\n\n\n\n\n\n\n\n\n\n\n\n\n\n

\n	\n	\n	\n
Delaware		001-01011		05-0494040
(State or other jurisdiction of incorporation)		(Commission File Number)		(IRS Employer Identification No.)

\n\n\n\n\n\n\n\n\n\n

One CVS Drive

Woonsocket, Rhode Island

02895

(Address of principal executive offices)

(Zip Code)

Registrant’s telephone number, including area code: (401) 765-1500

Former name or former address, if changed since last report: N/A

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

\n\n\n\n

☐

Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

\n\n\n\n

☐

Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

\n\n\n\n

☐

Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

\n\n\n\n

☐

Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:

\n\n\n\n\n\n\n\n\n\n\n\n\n\n

\n	\n	\n	\n
Title of each class		Trading Symbol(s)		Name of each exchange on which registered
Common Stock, par value $0.01 per share		CVS		New York Stock Exchange

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging growth company ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

\n\n\n

Item 7.01.

Regulation FD Disclosure.

On November 4, 2026, CVS Health Corporation (the “Company”) issued a press release announcing its intention to separate into two independent, publicly traded companies in a transaction that is intended to be tax-free to the Company and its shareholders for U.S. federal income tax purposes. A copy of the press release is attached hereto as Exhibit 99.1 and is incorporated herein by reference.

In accordance with General Instruction B.2 of Form 8-K, the information in this Item 7.01, including Exhibit 99.1, shall not be deemed “filed” for the purposes of Section 18 of the Securities Exchange Act of 1934, as amended, or otherwise subject to the liabilities of that section. The information in this Item 7.01 shall not be incorporated by reference into any filing or other document pursuant to the Securities Act of 1933, as amended, except as shall be expressly set forth by specific reference in such filing or document.

\n\n\n

Item 9.01.

Financial Statements and Exhibits.

\n\n\n\n

(d)

Exhibits.

\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n

\n\n	\n
Exhibit No.		Description
\n
99.1		Press Release, dated November 4, 2026 (furnished under Item 7.01).
\n
104		Cover Page Interactive Data File - the cover page XBRL tags are embedded within the Inline XBRL document.

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n

\n\n	\n
CVS HEALTH CORPORATION
\n
By:		/s/ Kristina V. Fink
\n		Kristina V. Fink
\n		Senior Vice President, Corporate Secretary and Chief Governance Officer

Dated: November 4, 2026

","zhKind","complete","CVS","公司与财报","aihot","/items/aphe9aiw777ioayxiprsqdvor","https://www.sec.gov/Archives/edgar/data/64803/000119312526446150/0001193125-26-446150-index.htm","rss-sec-xbrl","name","SEC · EDGAR 财务披露","kind","rss","firstParty","iconUrl","/api/img-proxy?u=https%3A%2F%2Fwww.sec.gov%2Fthemes%2Fcustom%2Fuswds_sec%2Fassets%2Fimg%2Ffavicons%2Fapple-touch-icon.png&mode=avatar&exp=1794960000&sig=44baa70fbeef50e6","iconSrcSet","/api/img-proxy?u=https%3A%2F%2Fwww.sec.gov%2Fthemes%2Fcustom%2Fuswds_sec%2Fassets%2Fimg%2Ffavicons%2Fapple-touch-icon.png&mode=avatar-48&exp=1794960000&sig=a4957e0f65b84b31 48w, /api/img-proxy?u=https%3A%2F%2Fwww.sec.gov%2Fthemes%2Fcustom%2Fuswds_sec%2Fassets%2Fimg%2Ffavicons%2Fapple-touch-icon.png&mode=avatar-96&exp=1794960000&sig=c50e8e83f0dcfb02 96w","changelogVersion","2026-10-01T08:00"]